Coronavirus Updates: Germany, UK approve human trials for COVID-19 vaccines

0
331
Coronavirus Updates: Germany, UK approve human trials for COVID-19 vaccines
Coronavirus Updates: Germany, UK approve human trials for COVID-19 vaccines

Scientists in both Germany and the United Kingdom will soon begin clinical trials using human volunteers in the race for a vaccine against the novel coronavirus.

Germany’s federal institute for vaccines and biomedical drugs announced Wednesday that it has approved its first human clinical trial for a COVID-19 vaccine. The potential vaccine is being developed by German firm BioNTech and is an RNA vaccine.

READ  Coronavirus USA Updates: Virginia reports 1st case of multisystem inflammatory syndrome in children

In the first phase of the clinical trial, 200 healthy volunteers between the ages of 18 and 55 will receive one or more variants of the vaccine candidate, according to a press release from the Paul Ehrlich Institute in Germany.

READ  Wetaskiwin Crime: The Most Dangerous Places in Canada

“Trials of vaccine candidates in humans are an important milestone on the road to safe and efficacious vaccines against COVID-19 for the population in Germany and internationally,” the institute said.

The clinical trial is only the fourth worldwide in which a preventive vaccine candidate targeting COVID-19 is tested in humans.

READ  Coronavirus USA Updates: Quest Diagnostics launches direct-to-consumer antibody testing service

Meanwhile, the first human trials for a COVID-19 vaccine begin in the United Kingdom on Thursday. The potential vaccine is being developed by researchers at the University of Oxford.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.